High-affinity association and degradation of 125I-labelled low density lipoproteins by human hepatocytes in primary culture. 1985

V A Kosykh, and S N Preobrazhensky, and V O Ivanov, and V P Tsibulsky, and V S Repin, and V N Smirnov

Catabolism of homologous low density lipoproteins (LDL) was studied in primary culture of human hepatocytes (HH). The cell association and degradation of 125I-labeled LDL (125I-LDL) were curvilinear functions of substrate concentration. Cell association and degradation of 125I-LDL were inhibited by excess unlabeled LDL. Reductive methylation of unlabeled LDL abolished its ability to complete with 125I-LDL for cell association and degradation. Preincubation of HH with unlabeled LDL caused a 63% inhibition of the 125I-LDL degradation. It is concluded that the catabolism of LDL by HH proceeds in part through a receptor-mediated pathway similar to that demonstrated on extrahepatic cells.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D008745 Methylation Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed) Methylations
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V A Kosykh, and S N Preobrazhensky, and V O Ivanov, and V P Tsibulsky, and V S Repin, and V N Smirnov
July 1989, Hepatology (Baltimore, Md.),
V A Kosykh, and S N Preobrazhensky, and V O Ivanov, and V P Tsibulsky, and V S Repin, and V N Smirnov
January 1981, Scandinavian journal of gastroenterology,
V A Kosykh, and S N Preobrazhensky, and V O Ivanov, and V P Tsibulsky, and V S Repin, and V N Smirnov
September 1979, Biochimica et biophysica acta,
V A Kosykh, and S N Preobrazhensky, and V O Ivanov, and V P Tsibulsky, and V S Repin, and V N Smirnov
May 1976, Biochimica et biophysica acta,
V A Kosykh, and S N Preobrazhensky, and V O Ivanov, and V P Tsibulsky, and V S Repin, and V N Smirnov
June 1980, Biochemical Society transactions,
V A Kosykh, and S N Preobrazhensky, and V O Ivanov, and V P Tsibulsky, and V S Repin, and V N Smirnov
July 1977, The Journal of clinical investigation,
V A Kosykh, and S N Preobrazhensky, and V O Ivanov, and V P Tsibulsky, and V S Repin, and V N Smirnov
August 1977, Biochimica et biophysica acta,
V A Kosykh, and S N Preobrazhensky, and V O Ivanov, and V P Tsibulsky, and V S Repin, and V N Smirnov
May 1985, Biochimica et biophysica acta,
V A Kosykh, and S N Preobrazhensky, and V O Ivanov, and V P Tsibulsky, and V S Repin, and V N Smirnov
July 1986, Metabolism: clinical and experimental,
V A Kosykh, and S N Preobrazhensky, and V O Ivanov, and V P Tsibulsky, and V S Repin, and V N Smirnov
January 1986, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!